[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"minimally-invasive-distal-pancreatectomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:minimally-invasive-distal-pancreatectomy":35},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":37,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":5},"100588255","laparoscopic-versus-robot-assisted-left-sided-pancreatectomy-for-benign-and-pre-malignant-lesions-diploma-3-100588255",false,"NCT06939023","Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)","Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3): an International Multicenter Patient-blinded Randomized Controlled Trial","DIPLOMA-3","Inclusion Criteria:\n\n* Age at least 18 years;\n* Indication for elective left-sided pancreatectomy, either spleen-preserving or non-preserving (because of proven or suspected left-sided benign or premalignant disease);\n* Both robot-assisted and laparoscopic left-sided pancreatectomy are technically feasible for resection, according to the local treatment team;\n* Fit to undergo left-sided pancreatectomy according to the surgeon and anaesthesiologist;\n* Written informed consent\n\nExclusion Criteria:\n\n* Suspected pancreatic ductal adenocarcinoma;\n* Tumor or cyst larger than 8 cm;\n* Required resection or ablation of organs other than pancreas and spleen;\n* Tumor involvement or abutment of major vessels (celiac trunk, mesenteric artery or vena cava);\n* Pregnancy;\n* Body mass index \\>40 kg\u002Fm2;\n* Participation in another study with interference of study outcomes","ALL","18 Years",{"count":20,"type":21},256,"ESTIMATED","INTERVENTIONAL",[24],"NA","The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.",[27,28,29,30,31,32,33,34,35,36],"Pancreatectomy","Distal Pancreatectomy (DP)","Pancreatic Neoplasms","Pancreatic Adenoma","Pancreatic Cyst","Pancreatic Cystadenoma","Surgery","Minimally Invasive Surgical Technique","Minimally Invasive Distal Pancreatectomy","Minimally Invasive Surgery",[38,39,40,41,42,43,44,45],"pancreas surgery","left-sided pancreatectomy","distal pancreatectomy","minimally invasive surgery","robot-assisted pancreatectomy","left pancreatectomy","robotic pancreatectomy","laparoscopic pancreatectomy","RECRUITING","2025-08-28",{"date":49,"type":50},"2025-09-04","ACTUAL",{"date":52,"type":50},"2025-06-01",{"date":54,"type":21},"2028-06-01",{"name":56,"class":57},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","OTHER"]